Dayton Children's Hospital
Rob Lober is a pediatric neurosurgeon and Director of the Living Biobank at Dayton Children’s Hospital, with the goal of improving the lives of brain tumor patients. He is committed to free, open access sharing of biological specimens and data in search of a cure. He is on the Board of Directors of the Children’s Brain Tumor Foundation and is the principal investigator of a translational research program that bridges advanced brain tumor imaging with molecular features of tumor growth and metabolism.
Rob’s research is focused on how stem cells, the immune system, and the tumor microenvironment contribute to glioma behavior. He is working with collaborators at Stanford and Indiana University to bring this work into the mathematical realm of machine learning to predict treatment responses based on advanced clinical imaging features.
Rob earned his MD and PhD at the Medical College of Georgia before neurosurgical training at Stanford. He completed fellowships in both Pediatric Neurosurgery and Pediatric Neuro-Oncology prior to joining the faculty at Dayton Children’s.
Dayton Children’s Hospital
Low-Grade Gliomas also called astrocytomas are the most common cancer of the central nervous system in children. They represent a heterogeneous group of tumors that can be discovered anywhere within the brain or spinal cord. Although surgical resection may be curative, up to 20% of children still su